Improved survival of cirrhotic patients with infections in Australian and New Zealand ICUs between 2005 and 2017
- PMID: 35532544
- DOI: 10.1111/liv.15285
Improved survival of cirrhotic patients with infections in Australian and New Zealand ICUs between 2005 and 2017
Abstract
Background & aims: Changes in outcomes of cirrhotic patients admitted to intensive care units (ICUs) with infections are poorly understood. We aimed to describe changes over time in outcomes for such patients and to compare them to other ICU admissions.
Methods: Analysis of consecutive admissions to 188 ICUs between 2005 and 2017 as recorded in the Australian and New Zealand Intensive Care Society Centre for Outcome and Research Evaluation Adult Patient Database.
Results: Admissions for cirrhotic patients with infections accounted for 4645 (0.6%) of 813 189 non-elective ICU admissions. Hospital mortality rate (35.5%) was significantly higher compared with other cirrhotic patients' admissions (28.5%), and other ICU admissions for infection (17.1%, p < .0001), and increased to 52.2% in the presence of acute-on-chronic liver failure (ACLF). Hospital mortality in cirrhotic patients' ICU admissions for infection decreased significantly over time (annual decline odds ratio, 0.97; 95% CI, 0.95-0.99, p = .002). There was a comparable reduction in-hospital mortality rates over time in other ICU admissions for infections and other cirrhotic patients' ICU admissions. However, mortality rates did not change over time in the ACLF subgroup. Median hospital and ICU length of stays for cirrhotic patients' ICU admissions for infections were 12.1 and 3.5 days, respectively, and decreased significantly by 1 day every 4 years in-hospital survivors(p < .0001).
Conclusion: Hospital mortality in ICU admissions for cirrhotic patients with infection is double that of non-cirrhotic patients with infection but has declined significantly over time. Outcomes in the subgroup with ACLF remained poor without significant improvement over the study period.
Keywords: ICU; cirrhosis; hospital mortality; incidence; infection; length of stay.
© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Similar articles
-
Declining Mortality of Cirrhotic Variceal Bleeding Requiring Admission to Intensive Care: A Binational Cohort Study.Crit Care Med. 2019 Oct;47(10):1317-1323. doi: 10.1097/CCM.0000000000003902. Crit Care Med. 2019. PMID: 31306178
-
Annual prevalence, characteristics, and outcomes of intensive care patients with skin or soft tissue infections in Australia and New Zealand: A retrospective cohort study between 2006-2017.Aust Crit Care. 2021 Sep;34(5):403-410. doi: 10.1016/j.aucc.2020.10.013. Epub 2021 Mar 1. Aust Crit Care. 2021. PMID: 33663947
-
Mortality and length-of-stay outcomes, 1993-2003, in the binational Australian and New Zealand intensive care adult patient database.Crit Care Med. 2008 Jan;36(1):46-61. doi: 10.1097/01.CCM.0000295313.08084.58. Crit Care Med. 2008. PMID: 18090383
-
Declining mortality in critically ill patients with cirrhosis in Australia and New Zealand between 2000 and 2015.J Hepatol. 2017 Dec;67(6):1185-1193. doi: 10.1016/j.jhep.2017.07.024. Epub 2017 Aug 9. J Hepatol. 2017. PMID: 28802877
-
Intensive care utilisation after elective surgery in Australia and New Zealand: getting the balance right.Aust Health Rev. 2023 Dec;47(6):718-720. doi: 10.1071/AH23187. Aust Health Rev. 2023. PMID: 38011832 Review.
Cited by
-
Long-term outcomes after ICU admission in critically ill patients with liver cirrhosis: An Australian state-wide cohort study.Hepatol Commun. 2025 Jul 21;9(8):e0762. doi: 10.1097/HC9.0000000000000762. eCollection 2025 Aug 1. Hepatol Commun. 2025. PMID: 40689506 Free PMC article.
-
Nonlinear association between AST/ALT ratio and 28-day all-cause mortality following ICU admission in critically ill cirrhotic patients: a retrospective cohort study.BMC Gastroenterol. 2025 May 13;25(1):367. doi: 10.1186/s12876-025-03966-0. BMC Gastroenterol. 2025. PMID: 40360992 Free PMC article.
References
REFERENCES
-
- Sakr Y, Jaschinski U, Wittebole X, Szakmany T, Lipman J, Ñamendys-Silva SA, Martin-Loeches I, Leone M, Lupu MN, Vincent JL, ICON Investigators. Sepsis in intensive care unit patients: worldwide data from the intensive care over nations audit. Open Forum Infect Dis 2018;5:ofy313. doi: 10.1093/ofid/ofy313
-
- Albillos A, Lario M, Álvarez-Mon M. Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance. J Hepatol. 2014;61:1385-1396.
-
- Arvaniti V, D'Amico G, Fede G, et al. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology. 2010;139:1246-1256.e5.
-
- Levesque E, Hoti E, Azoulay D, et al. Prospective evaluation of the prognostic scores for cirrhotic patients admitted to an Intensive Care Unit. J Hepatol. 2012;56:95-102.
-
- Arabi YM, Dara SI, Memish Z, et al. Antimicrobial therapeutic determinants of outcomes from septic shock among patients with cirrhosis. Hepatology Baltim Md. 2012;56:2305-2315.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources